Skip to main content
OpenTrials

Clinical trial condition

Relapsed and Bortezomib Refractory Multiple Myeloma

Explore clinical trials studying Relapsed and Bortezomib Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Relapsed and Bortezomib Refractory Multiple Myeloma trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Division of Hematology Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States
View all 13 locations